High dose epirubicin and cyclophosphamide (EC) vs cyclophosphamide, methotrexate, fluorouracil (CMF) as adjuvant chemotherapy in high risk premenopausal breast cancer patients (PTS). A prospective randomized trial

被引：0
|
作者：
Galligioni, E [1 ]
Cetto, G [1 ]
Nascimben, O [1 ]
Buonadaona, A [1 ]
Crivellari, D [1 ]
Molino, A [1 ]
Veronesi, A [1 ]
Graiff, C [1 ]
Barni, S [1 ]
Puccetti, C [1 ]
Ferrazzi, E [1 ]
Recaldin, E [1 ]
Sava, C [1 ]
Saracchini, S [1 ]
Sacco, C [1 ]
机构：
[1] Ctr Riferimento Oncol, GOCCNE, I-33081 Aviano, Italy
来源：
EUROPEAN JOURNAL OF CANCER | 1998年 / 34卷
关键词：
D O I：
10.1016/S0959-8049(97)89301-X
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P84
引用
收藏
页码：S36 / S36
页数：1
相关论文
共 50 条
  • [31] Adjuvant doxorubicin and cyclophosphamide versus cyclophosphamide, methotrexate, and 5-fluorouracil chemotherapy in premenopausal women with axillary lymph node positive breast carcinoma - Results of a randomized controlled trial
    Bang, SM
    Heo, DS
    Lee, KH
    Byun, JH
    Chang, HM
    Noh, DY
    Choe, KJ
    Bang, YJ
    Kim, SR
    Kim, NK
    CANCER, 2000, 89 (12) : 2521 - 2526
  • [32] Dose-dense sequential adjuvant chemotherapy with epirubicin, paclitaxel (taxol®) and CMF (E-T-CMF) vs epirubicin and CMF (E-CMF) in high-risk patients with breast cancer (BC).
    Fountzilas, G
    Papadimitriou, C
    Briassoulis, E
    Kalofonos, HP
    Christodoulou, C
    Razis, E
    Gogas, H
    BREAST CANCER RESEARCH AND TREATMENT, 2001, 69 (03) : 249 - 249
  • [33] Randomized phase III trial of adjuvant epirubicin followed by cyclophosphamide, methotrexate, and 5-fluorouracil (CMF) versus CMF followed by epirubicin in patients with node-negative or 1–3 node-positive rapidly proliferating breast cancer
    Dino Amadori
    Rosella Silvestrini
    Mario De Lena
    Francesco Boccardo
    Andrea Rocca
    Emanuela Scarpi
    Francesco Schittulli
    Mario Brandi
    Roberta Maltoni
    Patrizia Serra
    Riccardo Ponzone
    Nicoletta Biglia
    Lorenzo Gianni
    Amelia Tienghi
    Maria Rosaria Valerio
    Paola Bonginelli
    Laura Amaducci
    Marina Faedi
    Editta Baldini
    Angelo Paradiso
    Breast Cancer Research and Treatment, 2011, 125 : 775 - 784
  • [34] Q-TWiST analysis of cyclophosphamide, epirubicin, fluorouracil versus cyclophosphamide, methotrexate, fluorouracil treatment for premenopausal women with node-positive breast cancer
    Davide Radice
    Alberto Redaelli
    PharmacoEconomics, 2005, 23 : 69 - 75
  • [35] Q-TWiST analysis of cyclophosphamide, epirubicin, fluorouracil versus cyclophosphamide, methotrexate, fluorouracil treatment for premenopausal women with node-positive breast cancer
    Radice, D
    Redaelli, A
    PHARMACOECONOMICS, 2005, 23 (01) : 69 - 75
  • [36] Clinical Comparison on the Safety and Efficacy of Fluorouracil/Pirarubicin/Cyclophosphamide (FPC) with Fluorouracil/Epirubicin/Cyclophosphamide (FEC) as Postoperative Adjuvant Chemotherapy in Breast Cancer
    Li, Ying
    Tang, Jin-Hai
    Huang, Xin-En
    Li, Chen-guang
    ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2011, 12 (07) : 1795 - 1798
  • [37] Dose-dense sequential adjuvant chemotherapy with epirubicin, paclitaxel and CMF in high-risk breast cancer
    Fountzilas, G
    Papadimitriou, C
    Aravantinos, G
    Nicolaides, C
    Stathopoulos, G
    Bafaloukos, D
    Kalofonos, H
    Ekonomopoulos, T
    Skarlos, D
    Pavlidis, N
    Dimopoulos, AM
    ONCOLOGY, 2001, 60 (03) : 214 - 220
  • [38] Epirubicin Followed by Cyclophosphamide, Methotrexate and 5-Fluorouracil versus Paclitaxel Followed by Epirubicin and Vinorelbine in Patients with High-Risk Operable Breast Cancer
    Boccardo, Francesco
    Amadori, Dino
    Guglielmini, Pamela
    Sismondi, Piero
    Farris, Antonio
    Agostara, Biagio
    Gambi, Angelo
    Catalano, Giuseppina
    Faedi, Marina
    Rubagotti, Alessandra
    ONCOLOGY, 2010, 78 (3-4) : 274 - 281
  • [39] CLINICAL CONTROLLED TRIAL IN ADVANCED BREAST-CANCER - CMF (CYCLOPHOSPHAMIDE, METHOTREXATE, 5-FLUOROURACIL) VERSUS CMF+T (CYCLOPHOSPHAMIDE, METHOTREXATE, 5-FLUOROURACIL, TAMOXIFEN)
    HINDY, I
    NEOPLASMA, 1985, 32 (03) : 381 - 387
  • [40] Randomized trial comparing cyclophosphamide, epirubicin, and fluorouracil with cyclophosphamide, methotrexate, and fluorouracil in premenopausal women with node-positive breast cancer: Update of National Cancer Institute of Canada Clinical Trials Group Trial MA5
    Levine, MN
    Pritchard, KL
    Bramwell, VHC
    Shepherd, LE
    Tu, DS
    Paul, N
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (22) : 5166 - 5170
12345